AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
ALEXA.PA

Exacompta Clairefontaine S.A. (ALEXA.PA) fair value

Industrials · Business Equipment & Supplies · Euronext Paris · France
€147.00+0.00%
Market cap €166MNext earnings 2025-09-03Updated Oct 22, 2026
Our verdict
Trades 32% below our fair value
Price
€147.00
Model fair valueConfidence: good
€217
Model range
€46.65 to €457
Fair value €217
Price €147
3 models fit Exacompta Clairefontaine S.A. and they disagree: 1 of 3 land within 15% of the average.
Two or more of our models back this value.
Large discount(i)Bronze51
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionExacompta Clairefontaine S.A. (ALEXA.PA)
Fair value (3 models)
€217
ACCE price target
€175
Rating
Undervalued
Horizon
12 months
Fair value published on 22 Oct 2026, 12:04 CEST.
ACCE price target published on 23 Oct 2026, 01:53 CEST.
Rating published on 22 Oct 2026, 12:04 CEST.
Price used: €147 at the close on 22 Oct 2026, 17:30 CEST.
Models: Discounted cash flow, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
32.4% below
+47.9% to fair value
ACCE score
59
out of 100
P/E
6.6x
1-year return
-11.4%
Dividend yield
4.83%

Exacompta Clairefontaine S.A. in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Exacompta Clairefontaine makes paper stationery and office supplies in France, including its Clairefontaine notebooks, Exacompta filing and archiving products, and Rhodia pads, sold through retailers and its own distribution. The advantage is brand and shelf presence in European stationery, with a 52.3% gross margin that suggests real pricing power on those names. Revenue fell 3.3% and the operating margin is only 3.5%, so the case rests on whether the company can stabilise sales and lift profitability from a thin base. A 6.6x trailing P/E against a 4.6% ROE on a EUR 166M market cap is a cheap, low-return business, and the stock would only merit deeper work if management's cost actions or a volume recovery show up in the next reported half-year. Index membership is absent, which limits liquidity and the pool of natural buyers.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where ALEXA.PA's valuation models land
Price
€147.00
Model fair value
€217
Model range
€46.65 to €457
Fair value €217
Price €147
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-0.7%
1 month
-6.4%
3 months
-13.0%
6 months
-9.8%
YTD
-13.0%
1 year
-11.4%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:53 CESTACCE price target€175first publication€147
22 Oct 2026, 12:04 CESTRatingUndervaluedfirst publication€147
22 Oct 2026, 12:04 CESTFair value€217first publication€147

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full ALEXA.PA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth43Value100Quality51Momentum40Total59
Valuation
Trailing P/E
6.6x
Forward P/E
no data
PEG
0.12
P/B
0.32x
EV / Revenue
0.3x
Book value/sh
€488.96
Enterprise value
€250M
Profitability
ROE
4.6%
FCF yield
23.08%
ROIC
2.4%
Health and risk
Debt / equity
0.33
Dividend yield
4.83%
Beta
0.21

Price

-13.5% · 1Y

Ask anything about ALEXA.PA

Answered from Exacompta Clairefontaine S.A. fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 6.6x6.6xhigh 31.9x
ROEbetter than 67% of peers
low -97%5%high 13%
Div yieldbetter than 100% of peers
low 0.0%4.8%high 4.8%

Peers

Prices Oct 22, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
ALEXA.PA Exacompta Clairefontaine S.A.€147.00€21732% below6.6x4.6%5159
TTK.DE TAKKT AG€2.63----30.7%3533
AZK.MC Azkoyen, S.A.€10.10€1323% below15.8x12.9%7661
XRX Xerox Holdings Corporation Common Stock$2.79----97.1%2660
ITAB.ST ITAB Group AB (publ)kr 15.46kr 2742% below19.6x5.1%3955
SACI.PA Fiducial Office Solutions€36.00--31.9x-4.6%3950
ACTG Acacia Research Corporation (Acacia Tech) Common Stock$4.18$510% below--4.2%4050

Sector report card

Where ALEXA.PA ranks against its sector peers on each metric.

Computing percentiles…